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Abstract Protein tyrosine-pbosphorylation in primary human 
T-cells transduced with Tax1 of Human T-cell leukemia virus 
type I was investigated. In comparison with control T-cells, the 
level of protein tyrosine-phosphorylation after stimulation with 
anti-CD3 antibody increased significantly in Taxl-transduced 
T-cells. This enhancement in tyrosine-phosphorylation possibly 
accounted for the augmented proliferative response of these cells, 
which has been reported previously [J. Virol. 67 (1993) 1211- 
12171. 
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1. Introduction 
Human T-cell leukemia virus type 1 (HTLV-I), the causative 
agent of adult T-cell leukemia (ATL) and tropical spastic para- 
paresis (TSP)/HTLV-I-associated myelopathy(HAM), trans- 
forms normal T-cells in vitro [l]. Taxl, a transcriptional trans- 
activator of this virus, is supposed to be responsible for this 
process [2]. Transcriptional activation of cellular genes, such as 
IL-2 and IL-2Rol, by Tax1 is suspected to lead to T-cell trans- 
formation [3,4]. 
Previously, we established Tax 1 -transduced primary human 
CD4’ T-cells by using a retroviral vector system [5]. In compar- 
ison with the same subset of T-cells transduced with a control 
vector, we found that Taxl-transduced T-cells showed a greatly 
increased proliferative response to antigenic stimulation 
through T-cell receptor(stimulation with anti-CD3 antibody), 
whereas no significant levels of proliferation could be observed 
in both cell types without stimulation. This proliferation was 
mediated mainly by an IL-2 independent pathway because IL-2 
mRNA was barely detectable, and also because antibodies 
against IL-2 receptors had little inhibitory effect [6]. 
To elucidate the mechanism of this hyper-responsiveness, 
here we investigated protein tyrosine-phosphorylation and 
found that, compared to control T-cells, Taxl-transduced T- 
cells exhibited enhanced level of protein tyrosine-phosphoryla- 
tion in response to anti-CD3 stimulation both at early (l-2 min) 
and late (2448 h) time points after stimulation. 
2. Materials and methods 
2.1. Cells and cell culture 
Primary human T-cells derived from peripheral blood of a healthy 
donor were infected with a Taxl-expressing retroviral vector, DGL- 
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Taxl, or a control vector, DGL, followed by selection with G418. 
Detailed experimental procedure for establishment of these retroviral 
vector infected cells was described previously [5,6]. Over 99% of both 
infectants were CD3 positive, and over 95% were CD4 positive [6]. 
These cells were maintained in AIM-V medium(GIBC0) supplemented 
with 10% fetal calf serum(FCS), recombinant IL-2 (Takeda) at 10 
ng/ml, and 0.05 mM 2-mercaptoethanol. Cells at 5 to 6 months post- 
infection were used throughout this work. During this culturing period, 
both DGL-Taxl-infectants and DGL-infectants could be maintained 
in the same way in the IL-2 containing medium. 
2.2. Antibodies 
Monoclonal anti-CD3 antibody UCHT-1 was purchased from 
IMMUNOTECH. Purified rabbit polyclonal antibody specific for 
phosphotyrosine was purchased from ZYMED. Monoclonal anti- 
phosphotyrosine antibody PT66 was purchased from SIGMA. Both the 
polyclonal and monoclonal antibodies gave substantially same results. 
Monoclonal anti-Cdc2 antibody was purchased from Santa Cruz Bio- 
technology,Inc. Purified rabbit polyclonal anti-Cdk2 antibody and pu- 
rified rabbit polyclonal anti-FYN antibody were purchased from UBI. 
Monoclonal anti-LYN antibody Lyn9 [7] was kind gift of Drs. 
Yamamoto and Yamanashi (University of Tokyo). Rabbit polyclonal 
anti-ZAP70 antibody [8] was kind gift of Drs. Iwashima and Weiss 
(University of California San Francisco). A polyclonal antibody to 
LCK was raised in rabbit by immunization with LCK protein expressed 
in Escherichia coli. 
2.3. Itnmunoblotting 
Immunoblotting was performed essentially as described [9]. Briefly, 
5 x 10’ cells were pelleted and lysed in 100 ~1 of 2 x SDS-PAGE sample 
buffer containing 1 mM Na,VO,. 10 ~1 of each samples was fraction- 
ated on 10% SDS-PAGE, and the proteins were electrophoretically 
transferred to Immobilon (Millipore). After blocking with 3% BSA in 
TBS (10 mM Tris-HCl, pH 7.4, 140 mM NaCl) overnight at room 
temperature, the membranes were incubated with appropriate primary 
antibodies in TBS for 1 h. The membranes were then washed extensively 
with TBS containing 0.1% Tween 20, incubated for 1 h at room temper- 
ature with secondary antibodies, washed and developed with the Amer- 
sham ECL chemiluminescence reagent as directed by the manufacturer. 
2.4. Immunoprecipitation 
1 x 10’ cells were pelleted and lysed in 400~1 of 1% NP40 lysis buffer 
containing 10 mM Tris-HCl (pH 8.0), 150 mM NaCl, 10% glycerol, 2.5 
mM EDTA, 2 mM Na,VO,, 50 mM NaF, 20 mM Na,P>O,, 1 mM 
PMSF, 10 fig/ml leupeptin, 1% aprotinin at 4°C for 20 min. Insoluble 
material was removed by centrifugation at 4°C for 20 min at 10,000 x g. 
Cell lysates were incubated with antibodies for 2 hat 4”C, and then with 
protein G-Agarose for 1 h at 4°C. Immunoprecipitates were washed 
three times in lvsis buffer, and then susuended in 2 x SDS-PAGE sam- 
ple buffer containing 1 mM Na,VO, and analyzed by SDS-PAGE 
2.5. Affinity purification of p34”“’ 
Cell lysates, similarly prepared as in immunoprecipitation, were 
mixed with 20 ~1 of agarose beads conjugated with dl3”““, a well- 
known ~34’~‘~ binding protein [lO,ll] (Oncogene Science) for 3 h at 
4°C. Precipitate (affinity complex with pl3’““-beads)was used as affin- 
ity purified ~34~~~‘. and the supernatant was used as pre-cleared lysate. 
2.6. Stimulation with anti-CD3 antibody 
Before the stimulation, cells were cultured for 24 h in AIM-V medium 
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in the absence of FCS and IL-2 to obtain cells in the resting state. 
Stimulation with anti-CD3 antibody within 60 min was carried out as 
follows. 2 x IO” cells were suspended in 100 ~1 of HEPES-buffered 
saline containing 20 mM HEPES, pH 7.2, 140 mM NaCI, 3 mM KCI, 
I mM MgC12, 10 mM glucose, I mM CaCl,, incubated with lOpg/ml 
anti-CD3 antibody (UCHT-I) for IO min on ice, followed by addition 
of 80 &ml anti-mouse IgG for cross-linking, and incubated at 37°C 
for various time periods. Stimulation over 60 min was carried out by 
culturing the cells in anti-CD3 antibody (UCHT-I)-coated plates as 
described previously [6]. 2 x IO” cells were suspended in 2 ml of AIM-V 
medium containing 10% FCS, and cultured in UCHT-l-coated plates 
for various time periods. 
3. Results and discussion 
Taxl-transduced CD4’ T-cell population, PBLIDGL-Tax I. 
showed much higher (about IO times) proliferative response to 
anti-CD3 antibody stimulation than the same subset of T-cells 
transduced with a control vector, PBLlDGL [6]. Since there 
was no quantitative difference in CD3 antigen expression bc- 
tween the two cell types [6], we assumed that the difference in 
responsiveness originated in the process of signal transduction 
following stimulation with anti-CD3 antibody. To gain insight 
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Fig. I. Immunoblot analysis ofT-cells stimulated with anti-CD3 antibody. (A) Short-term kinetics of protein tyrosine-phosphorylation. (B) Long-term 
kinetics of protein tyrosine-phosphorylation. Both cell types were stimulated with anti-CD3 antibody (UCHT-I), and subjected to immunoblot 
analysis using rabbit polyclonal anti-phosphotyrosine antibody (ZYMED) as described in section 2. Arrow indicates the position of the 64 kDa 
protein. (C) Immunoblot analysis for p34cdcZ. The same filter as in (B) was subjected to immunoblot analysis with anti-Cdc2 monoclonal antibody 
(Santa Cruz Biotechnology, Inc.). Arrow indicates the position of the p34”“. 
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Fig. 2. Identification of the 34 kDa tyrosine-phosphoryrated protein as p34cdcZ. (A) From the lysate of PBL/DGL-Tax1 cells at 48 h after anti-CD3 
antibody stimulation, tyrosine phosphorylated proteins were immunoprecipitated and ~34’~‘~ was affinity purified as described in section 2. Precip- 
itates (lanes 1 and 3: immune complex with anti-phosphotyrosine antibody, lanes 2 and 4: affinity complex with pl3’““-beads)were subjected to 
immunoblot analysis using anti-phosphotyrosine polyclonal antibody(lanes 1 and 2) or antKdc2 monoclonal antibody (lanes 3 and 4). (B) Lysates 
from PBL/DGL-Tax1 cells at 48 h after anti-CD3 antibody stimulation were pre-cleared of ~34’~” as described in section 2. Lysates corresponding 
to 5 x lo4 cells, before (-) and after (+) me-clear, were subiected to immunoblot analysis using anti-phosphotyrosine antibody (lanes 1 and 2) or 
anti-Cdc2 antibody (lanes 3 and 4). . 
into the mechanism of this hyper-responsiveness, we first inves- 
tigated protein tyrosine-phosphorylation, which is known to be 
one of the earliest response to the stimulation with anti-CD3 
antibody [12,13]. Both infectants were stimulated with 
anti-CD3 antibody, and the state of protein tyrosine-phospho- 
rylation was examined by the immunoblotting with the anti- 
phosphotyrosine antibody. During the first hour after stimula- 
tion, as shown in Fig. 1 A, numerous tyrosine-phosphorylated 
proteins were detected transiently in both cell types, which is 
consistent with previous reports [1416]. PBLIDGL-Tax1 
showed markedly increased tyrosine-phosphorylation after the 
stimulation. At 30 s after the stimulation, PBL/DGL-Tax1 
showed a significant level of tyrosine-phosphorylation. In both 
cell types, tyrosine-phosphorylation reached a maximum be- 
tween 1 and 2 min and returned to the level of unstimulated 
condition by 15 min. The difference was quantitative rather 
than qualitative, because the patterns of tyrosine- 
phosphorylated proteins were almost same in both cell types, 
with the exception of a faint band at 64 kDa protein (indicated 
by an arrow in Fig. 1A) that was detected only in PBL/DGL- 
Tax 1. This 64 kDa protein could be seen even in time 0, and 
there was no significant change during this early stimulation 
period. 
In PBL/DGL-Taxl, a marked enhancement of tyrosine- 
phosphorylation was also seen much later after stimulation 
(Fig. 1 B), however, the pattern of tyrosine-phosphorylated pro- 
teins was different from that of early response. Gradual in- 
creases in tyrosine-phosphorylated proteins at 64 kDa and 
around 55 kDa were observed. Tyrosine-phosphorylation of 
these proteins was also seen in PBL/DGL, but the levels of 
phosphotyrosine were very low. Because tyrosine-phosphoryla- 
tion of these proteins remained at a constant low level through- 
out the early time-course (Fig. lA), these proteins seemed to 
be proteins phosphorylated by tyrosine kinases activated in the 
late stage of signal transduction. At 48 h after stimulation, 
tyrosine-phosphorylated 34 kDa protein was detected only in 
PBL/DGL-Tax1 (Fig. 1 B). Following serum stimulation of qui- 
escent NIH3T3 cells, p34 cdc2 is reported to be synthesized and 
tyrosine-phosphorylated in the S and G2 phases of the cell cycle 
[17]. From the molecular weight as well as the time-course of 
appearance, it is suggested that the tyrosine-phosphoryrated 34 
kDa protein observed in PBLIDGL-Tax1 at 48 h after stimula- 
tion was p3edc2. We tested this possibility by affinity purifica- 
tion of the tyrosine-phosphorylated proteins and ~34’~” from 
the lysate of PBL/DGL-Tax 1 at 48 h after stimulation; we used 
anti-phosphotyrosine antibody [18], and ~13”“” (a well-known 
P3pd”* binding protein [lO,l I])-agarose beads. Precipitates with 
the anti-phosphotyrosine antibody contained a 34 kDa protein 
that was recognized by anti-p34”d”2 antibody (Fig. 2A, lane 3). 
Likewise, ~13”“” -agarose beads precipitated a 34 kDa protein 
that was recognized both by anti-p34’d’2 antibody and anti- 
phosphotyrosine antibody (Fig. 2A, lanes 4,2). Moreover, after 
pre-clear of p3pdc2 by treating with pl3”““‘-beads, the 34 kDa 
protein-signal in the lysate was selectively reduced in im- 
munoblotting with anti-phosphotyrosine antibody(Fig. 2B, 
lanes 1,2). Since p33 cdk2 is also known to be tyrosine- 
phosphorylated and to bind ~13”““’ [ 191, we performed im- 
munoblot analysis with anti-p33cdk2 for the precipitates with 
pl3”““’ -agarose beads and found that it contained only a small 
amount of p33 tik2 (data not shown). These results indicated 
that the majority of tyrosine-phosphorylated 34 kDa protein 
detected in PBL/DGL-Tax1 at 48 h after stimulation was 
p34”d=*. Immunoblot analysis with anti-p34cdc2 antibody re- 
vealed that the difference between PBLlDGL and PBLIDGL- 
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Tax1 in tyrosine-phosphorylation of 34 kDa protein. as shown 
in Fig. 1 B, reflected a difference in the actual amount of ~34’“” 
protein (Fig. lC), and presumably reflected the difference in the 
number of cells entering S phase. 
The same pattern of tyrosine-phosphoryrated proteins as in 
PBL/DGL-Tax1 at 48 h after stimulation could be detected in 
HTLV-I immortalized human CD4’ helper T-cell clone, KN6- 
HT [20] (Fig. 3). Considering a plethora of evidence de- 
monstrating the importance of tyrosine-phosphorylated 
proteins in growth signal transduction pathway [21-241, identi- 
fication of other unknown tyrosine-phosphorylated proteins 
such as 64 kDa and 55 kDa proteins observed in PBL/DGL- 
Tax1 and KN6-HT, and the clarification of their functions 
should provide important insights into the mechanisms of the 
aberrant growth responses in these cells. For this purpose, we 
tested our cells with a panel of antibodies against well-known 
tyrosine- phosphorylated proteins whose molecular weights 
were reported to be similar to those of our unidentified pro- 
teins. Immunoprecipitates with anti-phosphotyrosine antibody 
were probed with antibodies against several kinds of src-family 
tyrosine kinase, CD5 [25,26], GAP associated p62 [27], She [28], 
IL-2Ry [29]. None of these antibodies reacted positively with 
our unidentified tyrosine-phosphorylated proteins, although 
we confirmed that these antibodies could recognize their re- 
spective antigens in the cell lysates derived from PBLIDGL- 
Tax1 or KN6-HT. Identification of the 64 kDa and 55 kDa 
proteins is still under way. 
To determine the kinase that was responsible for the elevated 
tyrosine-phosphoryration, expression of several kinds of src- 
family tyrosine kinase were compared between PBL/DGL and 
PBL/DGL-Tax1 We analyzed Fyn, Lck, and Lyn, because Fyn 
and Lck are known to be expressed in T-cells [30] and Lyn is 
Blot: a- P-Tyr 
Fig. 3. Tyrosine-phosphorylated proteins in HTLV-I infected and unin- 
fected human CD4’ help& T-ceil clone. An HTLV-I infected human 
CD4’ helper T-cell clone. KN6-HT 1201. and an uninfected same subset 
of the T-cell clone, FU-KOS3 (provided by Dr. Yasukawa, Ehime 
University), were maintained as described previously [20]. Whole cell 
lysates of these T-cell clones were prepared. and subjected to im- 
munoblot analysis using anti-phosphotyrosine antibody. -, HTLV-I 
uninfected; +. HTLV-I infected. 
stimulation 
Lyn Egg yn= 
Fig. 4. Immunoblot analysis for src-family tyrosine kinases. Whole cell 
lysates were prepared before(-) or 48h after(+) stimulation with anti- 
CD3 antibody, and subjected to immunoblot analysis using anti-Fyn 
polyclonal antibody or anti-Lck polyclonal antibody or anti-Lyn mon- 
oclonal antibody. Lyn9. 
reported to be expressed in HTLV-I infected cells [7]. Im- 
munoblot analyses of lysates from both cell types, either before 
or 48 h after stimulation, were performed against each specific 
antibody (Fig. 4). The Fyn expression level was almost the same 
in both cell types and there was no significant difference seen 
between the cells before and after the stimulation. Lck was also 
expressed similarly in both cell types, but its expression level 
decreased after stimulation. Although Lyn was expressed at a 
very low level in both cell types before stimulation, its expres- 
sion was upregulated specifically in PBL/DGL-Tax1 at 48 h 
after stimulation. We confirmed that this increase in Lyn pro- 
tein accompanied an increase in its mRNA by Northern blot 
analysis(data not shown). This result suggests that Lyn plays 
some role in the elevated tyrosine-phosphoryration of PBL/ 
DGL-Tax1 in the late stage of stimulation. In this context, it 
is noteworthy that Lyn is reported to be activated and to asso- 
ciate with ~34’~” m irradiated HL-60 cells [3 11. On the contrary. 
we could not detect any significant differences in expression 
and activity of the above src-family tyrosine kinases or in 
ZAP70 immediately after stimulation(data not shown). The 
precise mechanism of this upregulation of tyrosine-phosphoryl- 
ation remains to be resolved. But considering the function of 
Tax1 as a transcriptional activator, a likely possibility is that 
Tax1 trcms-activates genes encoding some as yet unidentified 
tyrosine kinase(s); this is, in fact, the case for Lyn [32]. Alterna- 
tively, genes for so called adapter proteins containing the SH2 
or SH3 domain, which facilitate the recruitment of substrates 
by activated tyrosine kinases [23]. may be trams-activated by 
Tax1 These unidentified genes may have enhancer motifs such 
as CRE, NFkb or SRE which are well-known Taxl-responsive 
enhancers [2]. Or, as is supposed in the case of Lyn [32], Tax1 
may stimulate the expression of these unidentified genes 
through interaction with a more general factor such as a tran- 
scriptional initiator. 
The elevated protein tyrosine-phosphorylation. we have de- 
scribed here, possibly accounts for the increased proliferative 
response of Taxl-transduced T-cells to the stimulation with 
anti-CD3 antibody [6]. And it is suggested that Tax1 can sensi- 
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tize T-cells to mitogenic signals by augmenting protein tyrosine- 
phosphorylation. 
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